Key Takeaways
- Johnson & Johnson has offered $5.5 billion to settle tens of thousands of lawsuits claiming its talcum powder products caused ovarian cancer.
- The proposed settlement covers around 76,000 claims, representing nearly all remaining talc claims.
- The company denies that its talc-based products caused cancer but stopped selling its talc-based baby powder in the US and Canada in 2020.
US pharmaceutical giant Johnson & Johnson has proposed a $5.5 billion settlement to resolve tens of thousands of lawsuits alleging its talcum powder products caused ovarian cancer, the company said Monday. The proposed settlement aims to end a long-standing legal battle that has weighed on the New Jersey-based firm for years.
J&J said the settlement covers around 76,000 claims, representing nearly all remaining talc claims. The firm denies that its talc-based products caused cancer but stopped selling its talc-based baby powder in the United States and Canada in 2020. Its vice president of litigation said the claims “lack scientific merit.”
According to the company, the proposed settlement will allow Johnson & Johnson to put this matter behind it and remain focused on its mission to develop medicines and devices that save lives. The company has previously settled most of the cases alleging that its talcum powder contained traces of asbestos blamed for causing cancer.
It also faces a lawsuit in the United Kingdom over similar claims filed in 2025. Claimants allege that either they or a family member developed forms of ovarian cancer or mesothelioma after using J&J’s baby powder. The law firm representing around 3,000 complainants estimates the compensation claim to be more than £1 billion ($1.3 billion).
Why This Matters
This settlement is significant as it brings an end to a long-standing legal battle and provides closure for the victims and their families. It also highlights the importance of corporate accountability and the need for companies to prioritize consumer safety and well-being.